2nd Next Generation RNA Therapeutics Summit
Bringing Next Generation RNA Therapies to Patients Faster
Newsletters and Deep Dive digital magazine
Bringing Next Generation RNA Therapies to Patients Faster
Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist.
As societies have modernised, fertility rates have declined substantially.
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox